252 related articles for article (PubMed ID: 30405416)
21. Analyzing Promiscuity at the Level of Active Compounds and Targets.
Bajorath J
Mol Inform; 2016 Dec; 35(11-12):583-587. PubMed ID: 27870240
[TBL] [Abstract][Full Text] [Related]
22. An up-to-date overview of computational polypharmacology in modern drug discovery.
Chaudhari R; Fong LW; Tan Z; Huang B; Zhang S
Expert Opin Drug Discov; 2020 Sep; 15(9):1025-1044. PubMed ID: 32452701
[TBL] [Abstract][Full Text] [Related]
23. The polypharmacology browser: a web-based multi-fingerprint target prediction tool using ChEMBL bioactivity data.
Awale M; Reymond JL
J Cheminform; 2017; 9():11. PubMed ID: 28270862
[TBL] [Abstract][Full Text] [Related]
24. Recent Overview of Resveratrol's Beneficial Effects and Its Nano-Delivery Systems.
Bohara RA; Tabassum N; Singh MP; Gigli G; Ragusa A; Leporatti S
Molecules; 2022 Aug; 27(16):. PubMed ID: 36014390
[TBL] [Abstract][Full Text] [Related]
25. Prediction of Promiscuity Cliffs Using Machine Learning.
Blaschke T; Feldmann C; Bajorath J
Mol Inform; 2021 Jan; 40(1):e2000196. PubMed ID: 32881355
[TBL] [Abstract][Full Text] [Related]
26. Polypharmacology rescored: protein-ligand interaction profiles for remote binding site similarity assessment.
Salentin S; Haupt VJ; Daminelli S; Schroeder M
Prog Biophys Mol Biol; 2014; 116(2-3):174-86. PubMed ID: 24923864
[TBL] [Abstract][Full Text] [Related]
27. Delineation of Polypharmacology across the Human Structural Kinome Using a Functional Site Interaction Fingerprint Approach.
Zhao Z; Xie L; Xie L; Bourne PE
J Med Chem; 2016 May; 59(9):4326-41. PubMed ID: 26929980
[TBL] [Abstract][Full Text] [Related]
28. Systematic computational identification of promiscuity cliff pathways formed by inhibitors of the human kinome.
Miljković F; Vogt M; Bajorath J
J Comput Aided Mol Des; 2019 Jun; 33(6):559-572. PubMed ID: 30915709
[TBL] [Abstract][Full Text] [Related]
29. Turning liabilities into opportunities: Off-target based drug repurposing in cancer.
Palve V; Liao Y; Remsing Rix LL; Rix U
Semin Cancer Biol; 2021 Jan; 68():209-229. PubMed ID: 32044472
[TBL] [Abstract][Full Text] [Related]
30. Polypharmacology of andrographolide: beyond one molecule one target.
Tran QTN; Tan WSD; Wong WSF; Chai CLL
Nat Prod Rep; 2021 Apr; 38(4):682-692. PubMed ID: 33021616
[TBL] [Abstract][Full Text] [Related]
31. Green Synthesis of a Novel Phytoalexin Derivative:
Roy LD; Kumar J
Anticancer Agents Med Chem; 2024; 24(1):66-76. PubMed ID: 37936468
[TBL] [Abstract][Full Text] [Related]
32. Identifying Promiscuous Compounds with Activity against Different Target Classes.
Feldmann C; Miljković F; Yonchev D; Bajorath J
Molecules; 2019 Nov; 24(22):. PubMed ID: 31752252
[TBL] [Abstract][Full Text] [Related]
33. Promiscuity in drug discovery on the verge of the structural revolution: recent advances and future chances.
Bolz SN; Schroeder M
Expert Opin Drug Discov; 2023; 18(9):973-985. PubMed ID: 37489516
[TBL] [Abstract][Full Text] [Related]
34. Regulating miRNAs Expression by Resveratrol: Novel Insights based on Molecular Mechanism and Strategies for Cancer Therapy.
Keshavarzmotamed A; Mousavi V; Masihipour N; Rahmati A; Mousavi Dehmordi R; Ghezelbash B; Alimohammadi M; Mafi A
Curr Mol Pharmacol; 2023 Oct; ():. PubMed ID: 37904563
[TBL] [Abstract][Full Text] [Related]
35. Addressing selective polypharmacology of antipsychotic drugs targeting the bioaminergic receptors through receptor dynamic conformational ensembles.
Selvam B; Porter SL; Tikhonova IG
J Chem Inf Model; 2013 Jul; 53(7):1761-74. PubMed ID: 23789628
[TBL] [Abstract][Full Text] [Related]
36. Medicinal Polypharmacology in the Clinic - Translating the Polypharmacolome into Therapeutic Benefit.
Rafehi M; Möller M; Ismail Al-Khalil W; Stefan SM
Pharm Res; 2024 Mar; 41(3):411-417. PubMed ID: 38366233
[TBL] [Abstract][Full Text] [Related]
37. Transcriptome inference and systems approaches to polypharmacology and drug discovery in herbal medicine.
Li P; Chen J; Zhang W; Fu B; Wang W
J Ethnopharmacol; 2017 Jan; 195():127-136. PubMed ID: 27894972
[TBL] [Abstract][Full Text] [Related]
38. Assessing protein kinase target similarity: Comparing sequence, structure, and cheminformatics approaches.
Gani OA; Thakkar B; Narayanan D; Alam KA; Kyomuhendo P; Rothweiler U; Tello-Franco V; Engh RA
Biochim Biophys Acta; 2015 Oct; 1854(10 Pt B):1605-16. PubMed ID: 26001898
[TBL] [Abstract][Full Text] [Related]
39. Polypharmacology: in silico methods of ligand design and development.
McKie SA
Future Med Chem; 2016 Apr; 8(5):579-602. PubMed ID: 27105127
[TBL] [Abstract][Full Text] [Related]
40. Local Alignment of Ligand Binding Sites in Proteins for Polypharmacology and Drug Repositioning.
Brylinski M
Methods Mol Biol; 2017; 1611():109-122. PubMed ID: 28451975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
